| |
|
|
Ahn-Gook Pharmaceutical (001540) |
|
|
KOSDAQ |
|
|
| Address |
ANGUK PHARCEUTICAL CO., 993-75, DAERIM 2-DONG,SEOUL |
| Home Page |
www.ahn-gook.com
|
| Established |
1959. 2.12 |
Tel |
02-3289-4200 |
| Listed |
2000. 6.15 |
IR |
|
| Common shares O/S |
11,500,000 |
President |
Eo,Jun Seon/Eo,Jin |
| Preferred shares O/S |
|
No.of Employees |
318(2007. 6) |
| The sales has been stagnant due to the temporal stop of Lebotention sales in relation to lawsuit and the slowdown of Anital. The profitability has improved due to the increased operating profitability resulting from the PR cost down and labor cost down. The financial structure is good based on the low debt ratio and affluent liquidity. |
| The sales has resumed on the Lebotension, a hypertension medicine as it has won the lawsuit in the higher court. The steady growth will be possible due to the expected launch of the prescription medicines in the second half of 2007. The profitability will go up with the high valued new products amid the reduced weight of the Prospan and Tobicom entering into the matured status. |
|
  |
(date: 2007.06, unit : %) |
| Name |
Eo Junseon |
Eo Jin |
Eo Gwang |
| Portion |
30.0 |
17.0 |
2.5 |
|
 |
(unit : %) |
| Sales |
Respiratory Drug |
21.0 |
Cost |
Raw Materials |
|
| Digestive Drug |
11.9 |
Labors |
|
| Others |
51.9 |
Overhead |
|
|
 |
(Unit : 100Mn.Won,Won) |
| Year |
00. 6 |
02. 9 |
- |
- |
- |
| Type |
LI |
SS |
- |
- |
- |
| Amount |
57.50 |
500.00 |
- |
- |
- |
|
|
|
|
